Kendra Brewster, in Perth Amboy, NJ - Licensed Vocational Nurse

Kendra Brewster, is a Licensed Vocational Nurse based in Perth Amboy, New Jersey. Kendra Brewster is licensed to practice in New Jersey (license number 26NP49645800) and her current practice location is 520 Convery Blvd, Perth Amboy, New Jersey. She can be reached at her office (for appointments etc.) via phone at (917) 676-9167.

NPI number for Kendra Brewster is 1063190809 and her current mailing address is 699 Broadway, ,, Bayonne, New Jersey. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1063190809.

Contact Information

	Kendra Brewster,
	520 Convery Blvd, Perth Amboy, NJ 08861-3021
	(917) 676-9167
	Not Available

Provider's Profile

Full Name	Kendra Brewster
Gender	Female
Speciality	Licensed Vocational Nurse
Location	520 Convery Blvd, Perth Amboy, New Jersey
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1063190809
Provider Enumeration Date: 07/11/2023
Last Update Date: 07/11/2023

Medical Identifiers

Medical identifiers for Kendra Brewster such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1063190809	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
164X00000X	Licensed Vocational Nurse	26NP49645800 (New Jersey)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Kendra Brewster is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Kendra Brewster, 699 Broadway, ,, Bayonne, NJ 07002 Ph: () -	Kendra Brewster, 520 Convery Blvd, Perth Amboy, NJ 08861-3021 Ph: (917) 676-9167

News Archive

Synergy Pharmaceuticals closes patient enrollment in plecanatide phase 2b clinical trial in IBS-C

Synergy Pharmaceuticals Inc. today announced it has closed patient enrollment in its plecanatide phase 2b clinical trial in irritable bowel syndrome with constipation.

Data from Phase 3 clinical trials of PROVENGE in advanced prostate cancer to be presented at ASCO 2010

Dendreon Corporation today announced the upcoming presentation of data from integrated analyses of three Phase 3 PROVENGE (sipuleucel-T) clinical trials of an autologous cellular immunotherapy in advanced prostate cancer, to be presented at the annual meeting of the American Society of Clinical Oncology in Chicago on Monday, June 7 at 8:00 a.m. CT.

New studies point that 38% of workers plan to leave public health workforce by 2020

New studies of the public health workforce reveal signs of unprecedented change ahead. Notably, 38 percent of state public health workers plan to leave the public health workforce by 2020, either to retire or to pursue positions in other sectors.

Study suggests using hypertonic saline infusions via peripheral catheter may help avoid complications

Current recommendations that a central catheter is required for continuous intravenous infusion of 3 percent sodium chloride solution should be re-evaluated, according to a study in the American Journal of Critical Care.

Kendra Brewster, - Licensed Vocational Nurse in Perth Amboy, NJ